Tumors establish resistance to immunotherapy by regulating T<sub>reg</sub>recruitment via CCR4Lisa A. Marshall, Oezcan Talay|Journal for ImmunoTherapy of Cancer|2020Cited by 141
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J. Jackson, Mikhail Zibinsky, Delia Bradford et al.|Journal of Medicinal Chemistry|2022Cited by 12